ELIZABETH CARTER: Open Payments
NPI 1457726846 · PROSPER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,583 in 129 payments from 18 companies in 2025. Trend: 2023 $2,805 · 2024 $2,729 · 2025 $2,583
Food & beverage: $2,503Education: $80
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 18 | $352 |
| Novartis Pharmaceuticals Corporation | 13 | $328 |
| Lilly USA, LLC | 11 | $238 |
| Amgen Inc. | 9 | $235 |
| GENZYME CORPORATION | 11 | $226 |
| Galderma Laboratories, L.P. | 16 | $208 |
| Janssen Biotech, Inc. | 7 | $163 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $151 |
| Incyte Corporation | 7 | $151 |
| ABBVIE INC. | 10 | $145 |
Products named: DUPIXENT, OTEZLA, NEMLUVIO, TREMFYA, OPZELURA, TALTZ, EBGLYSS, Zoryve.
Industry payments across TX — which companies pay providers there.
